Washington DC – April 9, 2012
WASHINGTON – According to the National Cancer Institute, 160,000 people die each year from lung cancer – making it the number one cause of cancer deaths in the United States.
A new blood test called “Paula’s Test” aims to change that by detecting lung cancer early.
Rockville, MD – March 7, 2012 -Genesys BioLabs, a division of 20/20 GeneSystems, Inc. announces today the launch of PAULA’s test, a blood test for the early detection of lung cancer, addressing the need for a widely useable early detection protocol for asymptomatic patients.
An estimated 160,340 Americans will die of Lung Cancer this year. The leading cancer killer, there is a less than 5 % survival for patients diagnosed at the latest stages. Read more…